Analyst firms · Mizuho · AMLX
Mizuho AMLX price target and rating history
Amylyx Pharmaceuticals Inc. (AMLX) · Health Care
Mizuho rates Amylyx Pharmaceuticals Inc. (AMLX) Outperform with a $7 price target, as of its latest action on Apr 7, 2025. It has published 3 rating actions on AMLX since March 2023, including 1 upgrade and 1 downgrade.
- Current rating
- Outperform
- Price target
- $7
- Median target, all firms
- Too few
- Actions on AMLX
- 3
Mizuho price target on AMLX
Every Mizuho rating on AMLX
- Apr 7, 2025
- Mar 18, 2024
- Mar 31, 2023
Questions about Mizuho and AMLX
- What is Mizuho's price target for AMLX?
- Mizuho's latest stated price target for Amylyx Pharmaceuticals Inc. (AMLX) is $7, from its action on Apr 7, 2025.
- What is Mizuho's rating on AMLX?
- Mizuho rates AMLX Outperform, a bullish rating, as of Apr 7, 2025.
- When did Mizuho last change its view on AMLX?
- On Apr 7, 2025, Mizuho upgrades to Outperform from Neutral, price target $7.
More AMLX rating histories
All Mizuho ratingsAMLX news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.